Related Experiment Video
Updated: Jan 20, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
TERT rs10069690 polymorphism and cancers risk: A meta-analysis
Guisheng He1, Tao Song1, Yazhen Zhang1
1Department of Surgical Oncology, Second Affiliated Hospital of Hainan Medical College, Haikou, Hainan Province, China.
The TERT rs10069690 gene polymorphism is linked to an increased overall cancer risk. This meta-analysis found it particularly associated with breast, ovarian, lung, thyroid, and renal cell carcinoma, but decreased risk for pancreatic cancer in Europeans.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The telomerase reverse transcriptase (TERT) gene polymorphism rs10069690 (C>T) has been investigated for its association with cancer risk.
- Previous studies have yielded inconclusive results regarding this link.
Purpose of the Study:
- To conduct a comprehensive meta-analysis to precisely estimate the relationship between the TERT rs10069690 polymorphism and cancer risk.
- To explore potential sources of heterogeneity through stratified analyses.
Main Methods:
- A meta-analysis was performed on 45 studies, encompassing 329,035 cancer cases and 730,940 controls.
- Searches were conducted in PubMed, Google Scholar, and Web of Science.
- Stratification by ethnicity, cancer type, control source, sample size, and genotyping methods was employed. Random effects models were used to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs).
Main Results:
- The TERT rs10069690 polymorphism was significantly associated with an overall increased cancer risk (OR = 1.09, 95% CI: 1.06-1.12).
- Stratification revealed increased risk for breast, ovarian, lung, thyroid, and renal cell carcinoma (RCC).
- A decreased risk was observed for pancreatic cancer in Europeans (OR = 0.93, 95% CI: 0.87-0.99). No significant association was found for prostate, leukemia, colorectal, or glioma.
Conclusions:
- The TERT rs10069690 polymorphism is suggested as a potential risk factor for various cancers, notably breast, ovarian, lung, thyroid, and RCC.
- Further functional studies are recommended to elucidate the precise role of this polymorphism in the development of cancer.
Related Concept Videos
Directing Effect of Substituents: meta-Directing Groups
Relative Risk
Cancer Survival Analysis
Single Nucleotide Polymorphisms-SNPs
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

